- Home
- FXNC vs TARA Comparison
FXNC vs TARA Comparison
Compare FXNC & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FXNC | TARA |
|---|---|---|
| Founded | 1907 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.4M | 236.1M |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FXNC | TARA |
|---|---|---|
| Price | $31.16 | $3.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 27.7K | ★ 367.3K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 96.00 | 38.25 |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $7,717,000.00 | $2,948,000.00 |
| Revenue This Year | $12.21 | N/A |
| Revenue Next Year | $2.93 | N/A |
| P/E Ratio | $26.50 | ★ N/A |
| Revenue Growth | ★ 7.40 | N/A |
| 52 Week Low | $21.59 | $3.02 |
| 52 Week High | $33.24 | $7.82 |
Technical Indicators
Market Signals| Indicator | FXNC | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 39.68 |
| Support Level | $26.51 | $3.73 |
| Resistance Level | $33.24 | $4.20 |
| Average True Range (ATR) | 0.80 | 0.15 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 25.82 | 15.19 |
Price Performance
Historical ComparisonAbout FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.